• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: INTEGRA LIFESCIENCES SWITZERLAND SAR HAKIM PROGRAMMABLE VALVE; CHPV

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

INTEGRA LIFESCIENCES SWITZERLAND SAR HAKIM PROGRAMMABLE VALVE; CHPV Back to Search Results
Catalog Number 823100
Device Problem Infusion or Flow Problem (2964)
Patient Problems Vomiting (2144); Weakness (2145); Injury (2348)
Event Date 11/05/2019
Event Type  Injury  
Manufacturer Narrative
To date the device involved in the reported incident has not been received for evaluation.An investigation has been initiated based on the reported information.
 
Event Description
It was reported that on (b)(6) 2019, the valve was implanted via v-p shunt to treat secondary normal pressure hydrocephalus (snph).An initial setting was 70mmh2o.On (b)(6) 2019, the patient developed vomiting and decreased activity.Ct scan was performed, and cerebral ventricular enlargement was observed; valve occlusion was suspected.On (b)(6) 2019, the valve was replaced with a new valve with no adverse consequences to the patient.
 
Manufacturer Narrative
Updated fields: d4.D10, g4, g7, h2, h3, h4, h6, h10 udi (b)(4) the hakim valve was received for evaluation.Dhr- conformed to the specifications when released to stock.Failure analysis- the valve passed the test for programming, occlusion, leaking, reflux, and pressure.No root cause could be determined, as the technician was unable to confirm the problem reported by the customer.The possible root cause for the problem reported by the customer could have been due to blockage due to buildup of protein, no occlusion/blockage issue was noted during the investigation.Between 05nov2019 and 30jun2020, approximately 2,200 mdrs submitted electronically by integra lifesciences via trackwise, integra's complaint handling system, were not received by cdrh due to a computer system issue.Within this time period, an error with integra's middleware, which facilitates communications between trackwise and the fda system, caused the complaint records to close and indicate we had received an acknowledgement 3 from the fda when we had not.Integra interpreted the acknowledgement as a successful submission; however, subsequent investigation revealed the acknowledgement 3 received was from our middleware and not from the fda (these acknowledgements have been retained as part of the documentation of the mdr).The malfunction was related to the relocation of the trackwise application to a new data center during the transition of integra's corporate headquarters from plainsboro, nj to princeton, nj.Previously, integra had been successfully receiving acknowledgements 1, 2, and 3 from the fda, and our records reflect these acknowledgements, including the date and time stamps.Capa pr 229048 and nc 20-011 have been opened by integra to further investigate the nonconformance and develop a corrective action plan.The middleware error has been corrected, and integra has filed mdrs since the correction and verified that the appropriate acknowledgements have been received from the fda.Integra is resubmitting all impacted mdr reports for the time period 05nov2019 through 30jun2020.Integra lifesciences contacted (b)(4) office of product evaluation and quality on july 8-9, 2020 to report these issues regarding mdr reports.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
HAKIM PROGRAMMABLE VALVE
Type of Device
CHPV
Manufacturer (Section D)
INTEGRA LIFESCIENCES SWITZERLAND SAR
rue girardet 29
rue girardet 29
le locle
SZ 
MDR Report Key10277011
MDR Text Key202699512
Report Number1226348-2019-00615
Device Sequence Number1
Product Code JXG
Combination Product (y/n)N
PMA/PMN Number
NA
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative
Type of Report Initial,Followup
Report Date 12/11/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received07/15/2020
Is this an Adverse Event Report? No
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date10/31/2023
Device Catalogue Number823100
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer01/07/2020
Date Manufacturer Received05/14/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Age57 YR
-
-